Arax Advisory Partners’s Aurora Cannabis ACB Stock Holding History

Arax Advisory Partners’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$318	Buy	114 +13	+13%	+$43	﹤0.01%	5056
2026 Q1	$331	Sell	101 -12	-11%	-$45	﹤0.01%	3479
2025 Q4	$478	Hold	113	–	–	﹤0.01%	3617
2025 Q3	$673	Buy	113 +12	+12%	+$59	﹤0.01%	3331
2025 Q2	$429	Buy	101 +100	+10,000%	+$485	﹤0.01%	2942
2025 Q1	$5	Hold	1	–	–	﹤0.01%	2653
2024 Q4	$5	Hold	1	–	–	﹤0.01%	2413
2024 Q3	$6	Hold	1	–	–	﹤0.01%	2608
2024 Q2	$5	Hold	1	–	–	﹤0.01%	2536
2024 Q1	$5	Hold	1	–	–	﹤0.01%	1310
2023 Q4	$7	Hold	1	–	–	﹤0.01%	1330
2023 Q3	$9	Hold	1	–	–	﹤0.01%	1316
2023 Q2	$8	Hold	1	–	–	﹤0.01%	1267
2023 Q1	$10	Hold	1	–	–	﹤0.01%	1269
2022 Q4	$13	Buy	+1	New	+$12	﹤0.01%	1269
2021 Q4	–	Sell	-1	Closed	–	–	1135
2021 Q3	$0	Hold	1	–	–	﹤0.01%	986
2021 Q2	$0	Buy	+1	New	+$87	﹤0.01%	914
2020 Q2	–	Sell	-126	Closed	-$14K	–	673
2020 Q1	$14K	Buy	126 +115	+1,045%	+$20.5K	﹤0.01%	492
2019 Q4	$3K	Hold	11	–	–	﹤0.01%	533
2019 Q3	$6K	Hold	11	–	–	﹤0.01%	491
2019 Q2	$11K	Buy	+11	New	+$11.1K	﹤0.01%	456
2018 Q4	$1K	Buy	+2	New	+$1.47K	﹤0.01%	538

Other funds holding ACB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Arax Advisory Partners's ACB Position: Q2 2026 in Review

Arax Advisory Partners increased its Aurora Cannabis (ACB) stake by 13% in Q2 2026, buying an estimated $43 and bringing the position to 114 shares worth $318. The position accounts for ﹤0.01% of the portfolio, ranked #5056.

Arax Advisory Partners first reported a position in ACB in Q4 2018 and has held it in 22 quarters since. The position peaked at $14K in Q1 2020. 149 funds tracked by Wall St. Rank hold ACB as of Q2 2026.

Arax Advisory Partners held 114 shares of Aurora Cannabis worth $318 as of Q2 2026.
Arax Advisory Partners bought 13 Aurora Cannabis shares in Q2 2026, an estimated $43.
Aurora Cannabis made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #5056 holding.
Arax Advisory Partners first reported a position in Aurora Cannabis in Q4 2018 and has held it in 22 quarters since.
Arax Advisory Partners's Aurora Cannabis position peaked at $14K in Q1 2020.
149 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.